Observational studyMedical oncology (Northwood, London, England)2022

Prospective assessment of AR splice variant and multi-biomarker expression on circulating tumor cells of mCRPC patients undergoing androgen receptor targeted agents: interim analysis of PRIMERA trial (NCT04188275).

Giulio Francolini et al.PubMed ↗Publisher ↗

No numbers read from the abstract.